Follows initiation of Phase 1a/1b study in the U.S. Company plans to include clinical centers in China to broaden geographic representation and accelerate patient enrollment into the Phase 1a/1b study SAN DIEGO and SHANGHAI, May 6, 2024 /PRNewswire/ — Adcentrx Therapeutics (“Adcentrx”),…